Laurus Labs Ltd.

₹1,090.45

-33.1 (-2.9%)

LAURUSLABS Share Price

Pharmaceuticals & Biotechnology

As on April 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 59,098 Cr

P/E Ratio164.11

Dividend Yield0.06 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,110.51	Bearish
10-DMA	1,117.81	Bearish
20-DMA	1,086.46	Bullish
50-DMA	1,046.13	Bullish
100-DMA	1,039.18	Bullish
200-DMA	965.97	Bullish

Historical Performance

1 Year

74.1%

3 Years

254.5%

5 Years

129.7%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	55,540	50,408	60,405	49,356	48,135
Total Expenditure	44,987	42,633	44,484	35,131	32,628
Other Income	751	263	60	153	237
Operating Profit	11,304	8,038	15,982	14,377	15,743
Interest	2,160	1,829	1,652	1,024	682
Depreciation	4,301	3,846	3,241	2,515	2,051
Profit Before Tax	4,843	2,364	11,089	10,838	13,011
Consolidated Net Profit	3,583	1,577	7,845	8,275	9,836
Adjusted EPS	7	3	15	15	18

Compounded Sales Growth

10 Years:33.2

5 Years:14.4

3 Years:2.4

TTM:2

Compounded Profit Growth

10 Years:39.3

5 Years:7

3 Years:-15.4

TTM:17.8

Stock Price CAGR

10 Years:N/A

5 Years:18.9

3 Years:52.5

TTM:76.7

Return on Equity

10 Years:4.2

5 Years:18.3

3 Years:14.6

last year:6.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	1,078	1,078	1,077	1,075	1,073
Total Reserves	43,387	39,817	39,177	32,346	24,853
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	11,933	11,592	11,795	9,280	6,928
Other Current Liabilities	7,797	6,107	6,408	8,397	3,672
Short Term Borrowings	17,150	13,893	9,958	9,107	8,861
Total Liabilities	93,356	83,870	76,604	69,680	57,507
Capital Work in Progress	4,584	4,228	5,508	8,132	3,622
Long Term Loans & Advances	1,634	835	1,606	841	1,085
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	2,071	1,472	1,089	1,345	884
Total Current Assets	43,323	38,350	34,617	33,446	30,749
Total Assets	93,356	83,870	76,604	69,680	57,507
Adjusted Book Value	82	76	75	62	48

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 164.11, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 51.8%, indicating sustained price appreciation.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹11304 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹55540 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1766053.9

No. of Shares: 1620 (Approx)

Performance:76.6%

P/L: ₹766053.9

NIFTY Performance: -1.4%

1 day Top Gainers